Contact Us
Wolfe Laboratories is now a subsidiary of Pace Analytical Life Sciences

Press Releases

Wolfe Laboratories Establishes Advisory Board

WATERTOWN, MA – (BUSINESS WIRE) – June 10, 2009 – Wolfe Laboratories, Inc. (WLI), a biopharmaceutical development company, announces the creation of an Advisory Board. Comprised of individuals well known in the biopharmaceutical field, the new Advisory Board will provide WLI management with their expertise and consultation in several areas, including DMPK, manufacturing, and strategic planning.


“The members of Wolfe Laboratories Advisory Board represent some of the best minds in biopharma and academia,” said Dr. Janet Wolfe, President and Founder of Wolfe Laboratories. “Their vast experience and success will help WLI make considerable gains in its customized translational research services and in its comprehensive IND-enabling programs. I am excited by each and every member’s willingness to join the Advisory Board and extremely grateful to have such a talented group of individuals to help Wolfe Laboratories achieve its long- and short-term goals.”


The new Advisory Board members include:



About Wolfe Laboratories, Inc. (WLI)

WLI is a biopharmaceutical development company that offers customized translational research services and comprehensive IND-enabling programs for biologics and small molecules. Through its development services in ADMET and CMC areas, as well as cGLP and cGMP testing, the company brings value to its clients by rapidly providing high quality project planning and execution through its experienced staff and management team. Drug Development Done Right. On Time. For more information, visit



(617) 923-7600